flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic disease in the Semaglutide in Patients with Obesity-Related

Clinical trial results The SURMOUNT clinical trial program demonstrated remarkable weight loss with tirzepatide

Icons with short descriptions reveal more benefits, such as 1:1 Consultations and Weekly Check-ins

Welcome a Healthier, Happier You Weight issues and related skin conditions dont have to be the bane of your existence

Eighteen physician-approved drips, every order reviewed by a board-certified MD and placed by a licensed provider

An engineered nanosugar enables rapid and sustained glucose-responsive insulin delivery in diabetic mice

Since many women of childbearing age may be interested in taking weight-loss drugs, some doctors worry this population doesnt know enough about the potential risks if an unplanned pregnancy were to happen while theyre on the immensely popular medications